Anti-Helicobacter pylori Properties of GutGard™. - Wikidata - awgldk - TriplyDB

Anti-Helicobacter pylori Properties of GutGard™.

Anti-Helicobacter pylori Properties of GutGard™.

http://www.wikidata.org/entity/Q37481544

about

Exploring alternative treatments for Helicobacter pylori infection Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.Phytochemicals in Infections: What Are We Doing Now?

P2860

Q26828017-41DA051B-29EA-4CB1-A5ED-93562EC22CAF Q38496942-E306FDBF-6727-464E-964E-DB59DD53F387 Q58789349-BD22B578-7209-40C3-97BC-18661786704D

P2860

Anti-Helicobacter pylori Properties of GutGard™.

http://www.wikidata.org/entity/Q37481544

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-Helicobacter pylori Properties of GutGard™.

@en

Anti-Helicobacter pylori Properties of GutGard™.

@nl

type

label

Anti-Helicobacter pylori Properties of GutGard™.

@en

Anti-Helicobacter pylori Properties of GutGard™.

@nl

prefLabel

Anti-Helicobacter pylori Properties of GutGard™.

@en

Anti-Helicobacter pylori Properties of GutGard™.

@nl

P1433

Q37481544-866981B2-032F-4DE7-A211-67CD0578DDA3

P1476

Q37481544-6E7442E8-72ED-46BD-8AA1-78EB7351F873

P2093

Q37481544-19E7978C-1BFB-4038-A877-84885A52D83F

Q37481544-608EF700-7032-4C5E-B3AC-C62627C6A19F

Q37481544-CBD9DC3C-7E16-4172-B30B-BB7D617C812E

Q37481544-E63FAD55-9429-4BD1-BE83-9B84D691C84A

Q37481544-E7E1CDC4-44AA-40A1-BD17-D2ED374F759D

P2860

Q37481544-01B5293F-2C43-418D-9F38-FB0076C3EAAC

Q37481544-04C8A55B-C67F-42BA-8820-DD47B7F7B904

Q37481544-0F77A728-E78E-45B5-BDE8-48E516C627FB

Q37481544-0FA640FD-3E40-401D-BA4E-20315982EE7C

Q37481544-1012141B-D069-43C2-8FEE-F36A74C53218

Q37481544-13F9DD9A-9D1F-4E77-AE73-29B0C51CCE5C

Q37481544-14256FEE-89BD-47B1-962B-B11A45F38387

Q37481544-19A32FCF-EA6E-4B1D-8931-06BFAB7AD334

Q37481544-243360A5-2EC4-4F93-9D5A-03E09FAEE87C

Q37481544-25096FB9-7A6B-41CA-A9B2-84D38521E7D2

P304

Q37481544-43C89178-610A-425A-9148-404FFC8A0D55

P31

Q37481544-31752D6A-0271-4BD9-AC12-EE978C945FD8

P356

Q37481544-748F80A1-F711-496D-A3B0-E4DD73A33B13

P433

Q37481544-3879A3A7-72EE-4DB7-9078-061E10A9F581

P478

Q37481544-5560B770-2723-486B-B31C-90D23C207D94

P577

Q37481544-F0922F9A-52D6-4F7F-8425-BFC3707E9957

P5875

Q37481544-C9415B12-AB45-4AB6-9470-00EA2BE19D75

P698

Q37481544-AEBD87D8-84D6-4E4B-B485-0E536E783537

P921

Q37481544-D2FC5CB3-15D8-4D67-9CDC-2D572839280F

P932

Q37481544-50D667FC-1EFF-4241-BDB6-F29BC589907D

P356

PNF.2013.18.2.104

P1433

Preventive nutrition and food science

P1476

Anti-Helicobacter pylori Properties of GutGard™.

@en

P2093

Boo Yong Lee

http://www.w3.org/2001/XMLSchema#string

Don Haeng Lee

http://www.w3.org/2001/XMLSchema#string

Hong Mei Zheng

http://www.w3.org/2001/XMLSchema#string

Jae Min Kim

http://www.w3.org/2001/XMLSchema#string

Woon Kyu Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

H pylori antibiotic resistance: prevalence, importance, and advances in testing

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines.

American College of Gastroenterology guideline on the management of Helicobacter pylori infection.

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.

A standardized protocol for repeated social defeat stress in mice.

Helicobacter pylori infection: anything new should we know?

Worldwide H. pylori antibiotic resistance: a systematic review.

Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root.

P304

104-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3746/PNF.2013.18.2.104

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259958123

http://www.w3.org/2001/XMLSchema#string

P698

24471118

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

3892500

http://www.w3.org/2001/XMLSchema#string